A common co-morbidity modulates disease expression and treatment efficacy in inherited cardiac sodium channelopathy
European Heart Journal

Abstract
Management of patients with inherited cardiac ion channelopathy is hindered by variability in disease severity and sudden cardiac death (SCD) risk. Here, we investigated the modulatory role of hypertrophy on arrhythmia and SCD risk in sodium channelopathy.
Follow-up data was collected from 164 individuals positive for the
This study provides the first evidence for a modulatory effect of co-existing cardiac hypertrophy on arrhythmia risk and treatment efficacy in inherited sodium channelopathy. Our findings emphasize the need for continued assessment and rigorous treatment of this co-morbidity in
Contributors

Mathilde R Rivaud
Author

John A Jansen
Author

Pieter G Postema
Author

Eline A Nannenberg
Author

Yuka Mizusawa
Author

Roel van der Nagel
Author

Rianne Wolswinkel
Author

Ingeborg van der Made
Author

Gerard A Marchal
Author

Sridharan Rajamani
Author

Luiz Belardinelli
Author

J Peter van Tintelen
Author

Michael W T Tanck
Author

Allard C van der Wal
Author

Jacques M T de Bakker
Author

Harold V van Rijen
Author

Esther E Creemers
Author

Arthur A M Wilde
Author

Maarten P van den Berg
Author

Toon A B van Veen
Author

Connie R Bezzina
Author

Carol Ann Remme
Author
You may be interested in



